A detailed history of Sectoral Asset Management Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 65,980 shares of OLMA stock, worth $416,993. This represents 0.66% of its overall portfolio holdings.

Number of Shares
65,980
Previous 118,480 44.31%
Holding current value
$416,993
Previous $1.28 Million 38.56%
% of portfolio
0.66%
Previous 0.64%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.41 - $16.46 $546,525 - $864,150
-52,500 Reduced 44.31%
65,980 $787,000
Q2 2024

Aug 13, 2024

SELL
$8.73 - $13.99 $187,695 - $300,785
-21,500 Reduced 15.36%
118,480 $1.28 Million
Q1 2024

May 14, 2024

BUY
$10.95 - $16.62 $1.32 Million - $2.01 Million
120,750 Added 627.93%
139,980 $1.58 Million
Q4 2023

Feb 14, 2024

SELL
$10.53 - $17.14 $4.41 Million - $7.17 Million
-418,422 Reduced 95.61%
19,230 $269,000
Q3 2023

Nov 14, 2023

SELL
$8.19 - $12.98 $1.73 Million - $2.73 Million
-210,701 Reduced 32.5%
437,652 $5.41 Million
Q2 2023

Aug 11, 2023

SELL
$3.22 - $9.65 $1.12 Million - $3.35 Million
-347,556 Reduced 34.9%
648,353 $5.85 Million
Q1 2023

May 12, 2023

SELL
$2.55 - $4.97 $1.14 Million - $2.22 Million
-445,896 Reduced 30.93%
995,909 $3.46 Million
Q4 2022

Feb 10, 2023

BUY
$2.27 - $3.76 $1.27 Million - $2.1 Million
558,749 Added 63.27%
1,441,805 $3.53 Million
Q3 2022

Nov 10, 2022

BUY
$2.72 - $5.88 $2.4 Million - $5.19 Million
883,056 New
883,056 $2.44 Million
Q4 2021

Feb 11, 2022

SELL
$8.75 - $30.71 $2.96 Million - $10.4 Million
-338,381 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$22.96 - $30.13 $3.48 Million - $4.57 Million
-151,639 Reduced 30.95%
338,381 $9.33 Million
Q2 2021

Aug 16, 2021

BUY
$21.15 - $36.14 $10.1 Million - $17.2 Million
477,120 Added 3698.6%
490,020 $13.7 Million
Q1 2021

May 14, 2021

BUY
$27.81 - $53.64 $358,749 - $691,956
12,900 New
12,900 $428,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $255M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.